Sagent Pharmaceuticals recalls 16mL Docetaxel vials due to particulate matter from stoppers. This may cause serious injury during injection. Check NDC 25021-254-08 and lot F1030001.
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Take action
Contact the company
📍Recalling firmSagent Pharmaceuticals1901 N Roselle Rd Ste 450 · Schaumburg, IL 60195
✎ GovInfoNow plain-language explainer
Sagent Pharmaceuticals is recalling 16mL Docetaxel injection vials because they may contain particulate matter from the stopper. This could cause serious injury if injected improperly. The recall affects prescription-only vials made in India with specific NDC and lot numbers. Read more at govinfonow.com/recall/32646-sagent-docetaxel-injection-recall-particulate-matter-risk.
“Sagent Docetaxel Injection Recall: Particulate Matter Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32646-sagent-docetaxel-injection-recall-particulate-matter-risk. Based on FDA recall #D-0554-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0554-2024%22&limit=1).
The FDA announced on May 28, 2024, that Sagent Pharmaceuticals is recalling Docetaxel Injection, USP due to the presence of particulate matter from the stopper. The agency issued recall number D-0554-2024 for the Class I voluntary recall.
How to tell if you have it
Brand: Sagent Pharmaceuticals
Product: Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial
NDC: 25021-254-08
Lot #: F1030001
Exp. Date: 12/31/2024
The hazard
The recall addresses the presence of particulate matter from the stopper in the drug product. The FDA classified this as a Class I hazard.
Context
GovInfoNow's records show Sagent Pharmaceuticals has issued three other recalls since July 11, 2023, including a May 4, 2026 recall for Busulfan Injection regarding failed impurities and an April 25, 2024 recall for MethylPREDNISolone Acetate Injectable Suspension involving black particulates. Other recent recalls of similar products include American Regent Papaverine HCl Injection (July 24, 2026), GE Healthcare Omnipaque Injection (March 24, 2026), and B. Braun Medical Lactated Ringer's Injection (April 28, 2026).
How to tell if you have this one
Check for NDC 25021-254-08 and lot number F1030001 on the vial label. This is a prescription-only 16mL Docetaxel injection vial made in India.
Brand
Sagent Pharmaceuticals
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class I
Status
Ongoing
Distribution
Nationwide within the USA.
NDC
25021-254-08, 25021-254-16
Recall number
Product, codes & lots
Quantity
D-0553-2024
Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08; Lot #: F1040001, Exp. Date 12/31/2024
762 vials
D-0554-2024
Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08; Lot #: F1030001, Exp. Date 12/31/2024
2806 vials
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Look for NDC 25021-254-08 and lot F1030001 on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 22 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0554-2024 (May 28, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0554-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.